Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Hepatitis

Free Subscription 04.02.2019 1 AIDS 1 Clin Infect Dis 3 Eur J Gastroenterol Hepatol 7 Hepatology 1 J Clin Gastroenterol 2 J Hepatol 1 J Infect Dis 1 J Med Virol 3 J Viral Hepat 1 J Virol 2 Lancet Gastroenterol Hepatol 1 Pediatr Infect Dis J 3 PLoS One 1 Transplantation 1 Virology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS

1. CHRISTIAN B, Fabian E, Macha I, Mpangala S, et al
   Hepatitis B virus coinfection is associated with high early mortality in HIV-infected Tanzanians on antiretroviral therapy.
   AIDS. 2019;33:465-473.
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

2. CHAILLON A, Rand EB, Reau N, Martin NK, et al
   Cost-Effectiveness of Universal Hepatitis C Virus Screening of Pregnant Women in The United States.
   Clin Infect Dis. 2019 Jan 28. pii: 5303781. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

3. VAN SANTEN DK, Schim van der Loeff MF, Cartier van Dissel J, Martens JPD, et al
   High proportions of liver fibrosis and cirrhosis in an ageing population of people who use drugs in Amsterdam, The Netherlands.
   Eur J Gastroenterol Hepatol. 2018;30:1168-1176.
   PubMed     Text format     Abstract available
   
   
4. ISMAIL WA, Yousef AE
   Effect of sofosbuvir plus daclatasvir for treatment of chronic hepatitis C on patients with psoriasis.
   Eur J Gastroenterol Hepatol. 2019 Jan 29. doi: 10.1097/MEG.0000000000001370.
   PubMed     Text format     Abstract available
   
   
5. YU JH, Suh YJ, Jin YJ, Heo NY, et al
   Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir.
   Eur J Gastroenterol Hepatol. 2019 Jan 28. doi: 10.1097/MEG.0000000000001357.
   PubMed     Text format     Abstract available
   
   

   
   Hepatology

6. HUANG AC, Mehta N, Dodge JL, Yao FY, et al
   Direct-acting Antivirals Do Not Increase the Risk of Hepatocellular Carcinoma Recurrence after Local-Regional Therapy or Liver Transplant Waitlist Dropout.
   Hepatology. 2018 Feb 24. doi: 10.1002/hep.29855.
   PubMed     Text format     Abstract available
   
   
7. ZEUZEM S, Bourgeois S, Greenbloom S, Buti M, et al
   JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-infected Patients without Cirrhosis: OMEGA-1.
   Hepatology. 2019 Jan 28. doi: 10.1002/hep.30527.
   PubMed     Text format     Abstract available
   
   
8. WANG CC, Kao JH
   The role of hepatitis B surface antigen in nucleos(t)ide analogues cessation among Asian chronic hepatitis B patients: friend or foe?
   Hepatology. 2019 Jan 31. doi: 10.1002/hep.30532.
   PubMed     Text format     Abstract available
   
   
9. LI T, Liu J, Zhang L, Xu A, et al
   Hepatitis B Surface Antigen in Nucleos(t)ide Analogues Cessation among Asian Chronic Hepatitis B Patients: an Important Addition.
   Hepatology. 2019 Jan 31. doi: 10.1002/hep.30531.
   PubMed     Text format     Abstract available
   
   
10. ISHIDA Y, Chung TL, Imamura M, Hiraga N, et al
    Acute hepatitis B virus infection in humanized chimeric mice has multiphasic viral kinetics.
    Hepatology. 2018;68:473-484.
    PubMed     Text format     Abstract available
    
    
11. BLAYA D, Aguilar-Bravo B, Hao F, Casacuberta-Serra S, et al
    Expression of microRNA-155 in inflammatory cells modulates liver injury.
    Hepatology. 2018;68:691-706.
    PubMed     Text format     Abstract available
    
    
12. FUNG J, Cheung KS, Wong DK, Mak LY, et al
    Long Term Outcomes and Predictive Scores for Hepatocellular Carcinoma and HBsAg Seroclearance after HBeAg Seroclearance.
    Hepatology. 2018 Mar 13. doi: 10.1002/hep.29874.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Gastroenterol

13. BUSH H, Rafiq N, Younossi ZM
    Implementation of Value-based Medicine (VBM) to Patients With Chronic Hepatitis C (HCV) Infection.
    J Clin Gastroenterol. 2019 Jan 23. doi: 10.1097/MCG.0000000000001174.
    PubMed     Text format     Abstract available
    
    

    
    J Hepatol

14. MARINO Z, Darnell A, Lens S, Sapena V, et al
    Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: relevance of non-characterized nodules.
    J Hepatol. 2019 Jan 23. pii: S0168-8278(19)30015.
    PubMed     Text format     Abstract available
    
    
15. 
    EASL Recommendations on Treatment of Hepatitis C 2016.
    J Hepatol. 2016 Sep 12. pii: S0168-8278(16)30489.
    PubMed     Text format    
    
    

    
    J Infect Dis

16. CHEN CH, Hung CH, Wang JH, Lu SN, et al
    The Incidence of Hepatitis B Surface Antigen Loss Between Hepatitis B E Antigen-Negative Noncirrhotic Patients Who Discontinued or Continued Entecavir Therapy.
    J Infect Dis. 2019 Jan 17. pii: 5299647. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Med Virol

17. KWON JH, Yoo SH, Nam SW, Kim HY, et al
    Clinical outcomes after the introduction of direct antiviral agents for patients infected with genotype 1b hepatitis C virus depending on the regimens: A multicenter study in Korea.
    J Med Virol. 2019 Jan 29. doi: 10.1002/jmv.25412.
    PubMed     Text format     Abstract available
    
    

    
    J Viral Hepat

18. JACK K, Thomson BJ, Irving WL
    Testing for hepatitis C virus infection in UK Prisons: what actually happens?
    J Viral Hepat. 2019 Jan 31. doi: 10.1111/jvh.13071.
    PubMed     Text format     Abstract available
    
    
19. KRANIDIOTI H, Manolakopoulos S, Kontos G, Breen MS, et al
    Immunological biomarkers as indicators for outcome after discontinuation of nucleos(t)ide analogue therapy in patients with HBeAg negative chronic hepatitis B.
    J Viral Hepat. 2019 Jan 31. doi: 10.1111/jvh.13068.
    PubMed     Text format     Abstract available
    
    
20. BLADOWSKA J, Pawlowski T, Fleischer-Stepniewska K, Knysz B, et al
    Interferon-free Therapy as the Cause of White Matter Tracts and Cerebral Perfusion Recovery in Patients with Chronic Hepatitis C.
    J Viral Hepat. 2019 Jan 31. doi: 10.1111/jvh.13069.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

21. WANG L, Teng JL, Lau SKP, Sridhar S, et al
    Transmission of A Novel Genotype Hepatitis E Virus from Bactrian Camels to Cynomolgus Macaques.
    J Virol. 2019 Jan 30. pii: JVI.02014-18. doi: 10.1128/JVI.02014.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

22. ZHOU K, Contag C, Whitaker E, Terrault N, et al
    Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses.
    Lancet Gastroenterol Hepatol. 2019 Jan 21. pii: S2468-1253(18)30308.
    PubMed     Text format     Abstract available
    
    
23. WEDEMEYER H
    The widespread rarity of HBsAg loss in chronic hepatitis B.
    Lancet Gastroenterol Hepatol. 2019 Jan 21. pii: S2468-1253(18)30384.
    PubMed     Text format    
    
    

    
    Pediatr Infect Dis J

24. LAPIDOT R, Alawdah L, Kohler JR, Paulson V, et al
    Hepatic Legionella pneumophila Infection in an Infant with Severe Combined Immunodeficiency.
    Pediatr Infect Dis J. 2017 Sep 20. doi: 10.1097/INF.0000000000001789.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

25. XIAO Y, Shen M, Ma S, Wen SW, et al
    The association between inter-twin birth weight discordance and hepatitis C: The United States 2011-2015 twin birth registration data.
    PLoS One. 2019;14:e0211683.
    PubMed     Text format     Abstract available
    
    
26. SHILI-MASMOUDI S, Sogni P, de Ledinghen V, Esterle L, et al
    Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.
    PLoS One. 2019;14:e0211286.
    PubMed     Text format     Abstract available
    
    
27. MANGIA A, Losappio R, Cenderello G, Potenza D, et al
    Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis.
    PLoS One. 2018;13:e0200568.
    PubMed     Text format     Abstract available
    
    

    
    Transplantation

28. VIONNET J, Yerly P, Aubert JD, Pascual M, et al
    Management of severe portopulmonary hypertension with dual oral therapy prior to liver transplantation.
    Transplantation. 2018 Feb 26. doi: 10.1097/TP.0000000000002142.
    PubMed     Text format    
    
    

    
    Virology

29. WALTERS AW, Kujawa MR, Albe JR, Reed DS, et al
    Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats.
    Virology. 2019;526:173-179.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: